1 Genital Herpes Treatment Market Overview 1.1 Product Overview and Scope of Genital Herpes Treatment 1.2 Genital Herpes Treatment Segment by Type 1.2.1 Global Genital Herpes Treatment Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Acyclovir 1.2.3 Valacyclovir 1.2.4 Famciclovir 1.3 Genital Herpes Treatment Segment by Application 1.3.1 Genital Herpes Treatment Sales Comparison by Application: (2021-2027) 1.3.2 HSV-1 1.3.3 HSV-2 1.4 Global Genital Herpes Treatment Market Size Estimates and Forecasts 1.4.1 Global Genital Herpes Treatment Revenue 2016-2027 1.4.2 Global Genital Herpes Treatment Sales 2016-2027 1.4.3 Genital Herpes Treatment Market Size by Region: 2016 Versus 2021 Versus 2027 2 Genital Herpes Treatment Market Competition by Manufacturers 2.1 Global Genital Herpes Treatment Sales Market Share by Manufacturers (2016-2021) 2.2 Global Genital Herpes Treatment Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Genital Herpes Treatment Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Genital Herpes Treatment Manufacturing Sites, Area Served, Product Type 2.5 Genital Herpes Treatment Market Competitive Situation and Trends 2.5.1 Genital Herpes Treatment Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Genital Herpes Treatment Players Market Share by Revenue 2.5.3 Global Genital Herpes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Genital Herpes Treatment Retrospective Market Scenario by Region 3.1 Global Genital Herpes Treatment Retrospective Market Scenario in Revenue by Region: 2016-2021 3.2 Global Genital Herpes Treatment Retrospective Market Scenario in Sales by Region: 2016-2021 3.3 North America Genital Herpes Treatment Market Facts & Figures by Country 3.3.1 North America Genital Herpes Treatment Sales by Country 3.3.2 North America Genital Herpes Treatment Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Genital Herpes Treatment Market Facts & Figures by Country 3.4.1 Europe Genital Herpes Treatment Sales by Country 3.4.2 Europe Genital Herpes Treatment Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Genital Herpes Treatment Market Facts & Figures by Region 3.5.1 Asia Pacific Genital Herpes Treatment Sales by Region 3.5.2 Asia Pacific Genital Herpes Treatment Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Genital Herpes Treatment Market Facts & Figures by Country 3.6.1 Latin America Genital Herpes Treatment Sales by Country 3.6.2 Latin America Genital Herpes Treatment Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Genital Herpes Treatment Market Facts & Figures by Country 3.7.1 Middle East and Africa Genital Herpes Treatment Sales by Country 3.7.2 Middle East and Africa Genital Herpes Treatment Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Genital Herpes Treatment Historic Market Analysis by Type 4.1 Global Genital Herpes Treatment Sales Market Share by Type (2016-2021) 4.2 Global Genital Herpes Treatment Revenue Market Share by Type (2016-2021) 4.3 Global Genital Herpes Treatment Price by Type (2016-2021) 5 Global Genital Herpes Treatment Historic Market Analysis by Application 5.1 Global Genital Herpes Treatment Sales Market Share by Application (2016-2021) 5.2 Global Genital Herpes Treatment Revenue Market Share by Application (2016-2021) 5.3 Global Genital Herpes Treatment Price by Application (2016-2021) 6 Key Companies Profiled 6.1 Teva 6.1.1 Teva Corporation Information 6.1.2 Teva Description and Business Overview 6.1.3 Teva Genital Herpes Treatment Sales, Revenue and Gross Margin (2016-2021) 6.1.4 Teva Product Portfolio 6.1.5 Teva Recent Developments/Updates 6.2 Abbott 6.2.1 Abbott Corporation Information 6.2.2 Abbott Description and Business Overview 6.2.3 Abbott Genital Herpes Treatment Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Abbott Product Portfolio 6.2.5 Abbott Recent Developments/Updates 6.3 Sun 6.3.1 Sun Corporation Information 6.3.2 Sun Description and Business Overview 6.3.3 Sun Genital Herpes Treatment Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Sun Product Portfolio 6.3.5 Sun Recent Developments/Updates 6.4 Mylan 6.4.1 Mylan Corporation Information 6.4.2 Mylan Description and Business Overview 6.4.3 Mylan Genital Herpes Treatment Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Mylan Product Portfolio 6.4.5 Mylan Recent Developments/Updates 6.5 Pfizer 6.5.1 Pfizer Corporation Information 6.5.2 Pfizer Description and Business Overview 6.5.3 Pfizer Genital Herpes Treatment Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Pfizer Product Portfolio 6.5.5 Pfizer Recent Developments/Updates 6.6 GlaxoSmithKline 6.6.1 GlaxoSmithKline Corporation Information 6.6.2 GlaxoSmithKline Description and Business Overview 6.6.3 GlaxoSmithKline Genital Herpes Treatment Sales, Revenue and Gross Margin (2016-2021) 6.6.4 GlaxoSmithKline Product Portfolio 6.6.5 GlaxoSmithKline Recent Developments/Updates 6.7 Dr. Reddy's 6.6.1 Dr. Reddy's Corporation Information 6.6.2 Dr. Reddy's Description and Business Overview 6.6.3 Dr. Reddy's Genital Herpes Treatment Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Dr. Reddy's Product Portfolio 6.7.5 Dr. Reddy's Recent Developments/Updates 6.8 Novartis 6.8.1 Novartis Corporation Information 6.8.2 Novartis Description and Business Overview 6.8.3 Novartis Genital Herpes Treatment Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Novartis Product Portfolio 6.8.5 Novartis Recent Developments/Updates 6.9 Valeant 6.9.1 Valeant Corporation Information 6.9.2 Valeant Description and Business Overview 6.9.3 Valeant Genital Herpes Treatment Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Valeant Product Portfolio 6.9.5 Valeant Recent Developments/Updates 7 Genital Herpes Treatment Manufacturing Cost Analysis 7.1 Genital Herpes Treatment Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Genital Herpes Treatment 7.4 Genital Herpes Treatment Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Genital Herpes Treatment Distributors List 8.3 Genital Herpes Treatment Customers 9 Genital Herpes Treatment Market Dynamics 9.1 Genital Herpes Treatment Industry Trends 9.2 Genital Herpes Treatment Growth Drivers 9.3 Genital Herpes Treatment Market Challenges 9.4 Genital Herpes Treatment Market Restraints 10 Global Market Forecast 10.1 Genital Herpes Treatment Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Genital Herpes Treatment by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Genital Herpes Treatment by Type (2022-2027) 10.2 Genital Herpes Treatment Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Genital Herpes Treatment by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Genital Herpes Treatment by Application (2022-2027) 10.3 Genital Herpes Treatment Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Genital Herpes Treatment by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Genital Herpes Treatment by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Genital Herpes Treatment Sales (K Pcs) Growth Rate Comparison by Type (2021-2027) Table 2. Global Genital Herpes Treatment Sales (K Pcs) Comparison by Application (2021-2027) Table 3. Global Genital Herpes Treatment Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Genital Herpes Treatment Covered in This Study Table 5. Global Genital Herpes Treatment Sales (K Pcs) of Key Manufacturers (2016-2021) Table 6. Global Genital Herpes Treatment Sales Share by Manufacturers (2016-2021) Table 7. Global Genital Herpes Treatment Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Genital Herpes Treatment Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Genital Herpes Treatment Average Price (USD/Pcs) of Key Manufacturers (2016-2021) Table 10. Manufacturers Genital Herpes Treatment Manufacturing Sites and Area Served Table 11. Manufacturers Genital Herpes Treatment Product Type Table 12. Global Genital Herpes Treatment Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Genital Herpes Treatment by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Genital Herpes Treatment as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Genital Herpes Treatment Sales by Region (2016-2021) & (K Pcs) Table 16. Global Genital Herpes Treatment Sales Market Share by Region (2016-2021) Table 17. Global Genital Herpes Treatment Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Genital Herpes Treatment Sales by Country (2016-2021) & (K Pcs) Table 19. North America Genital Herpes Treatment Sales Market Share by Country (2016-2021) Table 20. North America Genital Herpes Treatment Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Genital Herpes Treatment Revenue Market Share by Country (2016-2021) Table 22. Europe Genital Herpes Treatment Sales by Country (2016-2021) & (K Pcs) Table 23. Europe Genital Herpes Treatment Sales Market Share by Country (2016-2021) Table 24. Europe Genital Herpes Treatment Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Genital Herpes Treatment Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Genital Herpes Treatment Sales by Region (2016-2021) & (K Pcs) Table 27. Asia Pacific Genital Herpes Treatment Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Genital Herpes Treatment Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Genital Herpes Treatment Revenue Market Share by Region (2016-2021) Table 30. Latin America Genital Herpes Treatment Sales by Country (2016-2021) & (K Pcs) Table 31. Latin America Genital Herpes Treatment Sales Market Share by Country (2016-2021) Table 32. Latin America Genital Herpes Treatment Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Genital Herpes Treatment Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Genital Herpes Treatment Sales by Country (2016-2021) & (K Pcs) Table 35. Middle East and Africa Genital Herpes Treatment Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Genital Herpes Treatment Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Genital Herpes Treatment Revenue Market Share by Country (2016-2021) Table 38. Global Genital Herpes Treatment Sales (K Pcs) by Type (2016-2021) Table 39. Global Genital Herpes Treatment Sales Market Share by Type (2016-2021) Table 40. Global Genital Herpes Treatment Revenue (Million US$) by Type (2016-2021) Table 41. Global Genital Herpes Treatment Revenue Share by Type (2016-2021) Table 42. Global Genital Herpes Treatment Price (USD/Pcs) by Type (2016-2021) Table 43. Global Genital Herpes Treatment Sales (K Pcs) by Application (2016-2021) Table 44. Global Genital Herpes Treatment Sales Market Share by Application (2016-2021) Table 45. Global Genital Herpes Treatment Revenue (Million US$) by Application (2016-2021) Table 46. Global Genital Herpes Treatment Revenue Share by Application (2016-2021) Table 47. Global Genital Herpes Treatment Price (USD/Pcs) by Application (2016-2021) Table 48. Teva Corporation Information Table 49. Teva Description and Business Overview Table 50. Teva Genital Herpes Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 51. Teva Genital Herpes Treatment Product Table 52. Teva Recent Developments/Updates Table 53. Abbott Corporation Information Table 54. Abbott Description and Business Overview Table 55. Abbott Genital Herpes Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 56. Abbott Genital Herpes Treatment Product Table 57. Abbott Recent Developments/Updates Table 58. Sun Corporation Information Table 59. Sun Description and Business Overview Table 60. Sun Genital Herpes Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 61. Sun Genital Herpes Treatment Product Table 62. Sun Recent Developments/Updates Table 63. Mylan Corporation Information Table 64. Mylan Description and Business Overview Table 65. Mylan Genital Herpes Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 66. Mylan Genital Herpes Treatment Product Table 67. Mylan Recent Developments/Updates Table 68. Pfizer Corporation Information Table 69. Pfizer Description and Business Overview Table 70. Pfizer Genital Herpes Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 71. Pfizer Genital Herpes Treatment Product Table 72. Pfizer Recent Developments/Updates Table 73. GlaxoSmithKline Corporation Information Table 74. GlaxoSmithKline Description and Business Overview Table 75. GlaxoSmithKline Genital Herpes Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 76. GlaxoSmithKline Genital Herpes Treatment Product Table 77. GlaxoSmithKline Recent Developments/Updates Table 78. Dr. Reddy's Corporation Information Table 79. Dr. Reddy's Description and Business Overview Table 80. Dr. Reddy's Genital Herpes Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 81. Dr. Reddy's Genital Herpes Treatment Product Table 82. Dr. Reddy's Recent Developments/Updates Table 83. Novartis Corporation Information Table 84. Novartis Description and Business Overview Table 85. Novartis Genital Herpes Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 86. Novartis Genital Herpes Treatment Product Table 87. Novartis Recent Developments/Updates Table 88. Valeant Corporation Information Table 89. Valeant Description and Business Overview Table 90. Valeant Genital Herpes Treatment Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2016-2021) Table 91. Valeant Genital Herpes Treatment Product Table 92. Valeant Recent Developments/Updates Table 93. Production Base and Market Concentration Rate of Raw Material Table 94. Key Suppliers of Raw Materials Table 95. Genital Herpes Treatment Distributors List Table 96. Genital Herpes Treatment Customers List Table 97. Genital Herpes Treatment Market Trends Table 98. Genital Herpes Treatment Growth Drivers Table 99. Genital Herpes Treatment Market Restraints Table 100. Global Genital Herpes Treatment Sales Forecast by Type (2022-2027) & (K Pcs) Table 101. Global Genital Herpes Treatment Sales Market Share Forecast by Type (2022-2027) Table 102. Global Genital Herpes Treatment Revenue Forecast by Type (2022-2027) & (US$ Million) Table 103. Global Genital Herpes Treatment Revenue Market Share Forecast by Type (2022-2027) Table 104. Global Genital Herpes Treatment Sales Forecast by Application (2022-2027) & (K Pcs) Table 105. Global Genital Herpes Treatment Sales Market Share Forecast by Application (2022-2027) Table 106. Global Genital Herpes Treatment Revenue Forecast by Application (2022-2027) & (US$ Million) Table 107. Global Genital Herpes Treatment Revenue Market Share Forecast by Application (2022-2027) Table 108. Global Genital Herpes Treatment Sales Forecast by Region (2022-2027) & (K Pcs) Table 109. Global Genital Herpes Treatment Sales Market Share Forecast by Region (2022-2027) Table 110. Global Genital Herpes Treatment Revenue Forecast by Region (2022-2027) & (US$ Million) Table 111. Global Genital Herpes Treatment Revenue Market Share Forecast by Region (2022-2027) Table 112. Research Programs/Design for This Report Table 113. Key Data Information from Secondary Sources Table 114. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Genital Herpes Treatment Figure 2. Global Genital Herpes Treatment Market Share by Type in 2020 & 2027 Figure 3. Acyclovir Product Picture Figure 4. Valacyclovir Product Picture Figure 5. Famciclovir Product Picture Figure 6. Global Genital Herpes Treatment Market Share by Application in 2020 & 2027 Figure 7. HSV-1 Figure 8. HSV-2 Figure 9. Global Genital Herpes Treatment Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 10. Global Genital Herpes Treatment Market Size 2016-2027 (US$ Million) Figure 11. Global Genital Herpes Treatment Sales 2016-2027 (K Pcs) Figure 12. Global Genital Herpes Treatment Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 13. Genital Herpes Treatment Sales Share by Manufacturers in 2020 Figure 14. Global Genital Herpes Treatment Revenue Share by Manufacturers in 2020 Figure 15. The Global 5 and 10 Largest Genital Herpes Treatment Players: Market Share by Revenue in 2020 Figure 16. Genital Herpes Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 17. Global Genital Herpes Treatment Sales Market Share by Region (2016-2021) Figure 18. Global Genital Herpes Treatment Sales Market Share by Region in 2020 Figure 19. Global Genital Herpes Treatment Revenue Market Share by Region (2016-2021) Figure 20. Global Genital Herpes Treatment Revenue Market Share by Region in 2020 Figure 21. U.S. Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 22. Canada Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 23. Germany Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 24. France Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 25. U.K. Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Italy Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Russia Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. China Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. Japan Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. South Korea Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. India Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. Australia Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Taiwan Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. Indonesia Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. Thailand Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Malaysia Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Philippines Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Vietnam Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Mexico Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Brazil Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Argentina Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Turkey Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Saudi Arabia Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. U.A.E Genital Herpes Treatment Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Sales Market Share of Genital Herpes Treatment by Type (2016-2021) Figure 46. Sales Market Share of Genital Herpes Treatment by Application (2016-2021) Figure 47. Sales Market Share of Genital Herpes Treatment by Application in 2020 Figure 48. Revenue Share of Genital Herpes Treatment by Application (2016-2021) Figure 49. Revenue Share of Genital Herpes Treatment by Application in 2020 Figure 50. Manufacturing Cost Structure of Genital Herpes Treatment Figure 51. Manufacturing Process Analysis of Genital Herpes Treatment Figure 52. Genital Herpes Treatment Industrial Chain Analysis Figure 53. Channels of Distribution Figure 54. Distributors Profiles Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

Teva Abbott Sun Mylan Pfizer GlaxoSmithKline Dr. Reddy's Novartis Valeant